Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2) - Wikidata - wikimedia - TriplyDB

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

http://www.wikidata.org/entity/Q35546451

about

Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1.Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor.Conformational switches in the VPAC(1) receptor.Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

P2860

Q34079450-CAC0E2F5-1FAE-4273-B5FD-160046DA34DC Q34454930-8DD5CDBE-CBB2-4812-8097-7544D5648F48 Q34532319-16FD905F-DE52-4D72-BC3E-106E973DA4E8 Q35971449-E523DA39-214F-43A0-8C97-4B0CEA8F01AA Q37177027-7B051660-A41F-4EBB-B422-CC8A3A7F5543 Q37909492-6D79AAEA-FE51-4A59-83B6-6875C08B2B8A Q41645695-5D6BDA13-0609-47FC-BF17-8766E29FB7A4 Q42567375-69967B31-EA2E-499B-BD5A-30BBBDA78414

P2860

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

http://www.wikidata.org/entity/Q35546451

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@ast

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@en

type

label

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@ast

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@en

prefLabel

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@ast

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@en

P1433

Q35546451-BB0E8708-F8E9-4225-BDCA-D7FC968730D3

P1476

Q35546451-85E7344A-DB7A-43C3-8A5E-AA28743DDE34

P2093

Q35546451-29F50B52-CD3B-40F1-9BAE-46577768FB69

Q35546451-98F5C00F-C7ED-477F-A3FD-2BF44B049C6D

Q35546451-AB394805-6759-4148-A3A9-02FC084ADEC1

P2860

Q35546451-1E1A338C-AA69-469D-B46A-F06729883581

Q35546451-260A893F-DBA4-4430-9B94-1BDA7B49AC2F

Q35546451-288F45F9-9B32-4B70-9DBA-956F7B7B8803

Q35546451-3893858F-2AF4-44E7-9D93-8984306657CC

Q35546451-3935DB39-4413-4F7C-9CB9-9C2B1C34E13F

Q35546451-3A6D05D4-480E-4F56-9BC0-73E182B7D1AF

Q35546451-3F20474B-737B-4E95-8E38-F445ADC168D9

Q35546451-45BE0068-F2E1-4166-9375-954EBBAA8CB2

Q35546451-499DF235-A71C-4AA1-9A0C-074C820086B2

Q35546451-4CB93A9A-418A-46DB-8114-5C22BD05217B

P304

Q35546451-D5199BA7-06ED-4FF3-B151-986127C3315E

P31

Q35546451-54A9C011-95EA-417A-99BE-282A3FF5D76C

P356

Q35546451-BD6F9921-1F4A-4427-B650-7A6BE6FFF767

P407

Q35546451-98D647C5-256D-41D1-982D-B5E0CA9807D8

P433

Q35546451-05F6A414-A303-40EB-B446-4991CBE98AB8

P478

Q35546451-7672994E-D213-400B-9950-FC8B0780BF40

P577

Q35546451-4AA71C36-E67C-4C46-9DF5-95DAFB583C5B

P5875

Q35546451-43F3AAEF-4ED2-43EB-B0F1-EBDE79A62F01

P698

Q35546451-CCB5F39F-C8EC-4CA7-B568-2F85E6B30478

P932

Q35546451-524D9EA6-2555-401A-8F09-0AF7BA1E5DD7

P356

P1433

British Journal of Pharmacology

P1476

Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)

@en

P2093

Ingrid Langer

http://www.w3.org/2001/XMLSchema#string

Nathalie Gaspard

http://www.w3.org/2001/XMLSchema#string

Patrick Robberecht

http://www.w3.org/2001/XMLSchema#string

P2860

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns

Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung

Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors

Seven-transmembrane receptors

Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

The significance of vasoactive intestinal peptide in immunomodulation.

Roles of G-protein-coupled receptor dimerization.

P304

1051-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0706816

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7001239

http://www.w3.org/2001/XMLSchema#string

P698

16783404

http://www.w3.org/2001/XMLSchema#string

P932

1752023

http://www.w3.org/2001/XMLSchema#string